Literature DB >> 9165539

Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake.

A E Hawley1, L Illum, S S Davis.   

Abstract

PURPOSE: Nanospheres can be utilised for the targeting of drugs and diagnostic agents to the regional lymph nodes. The surface modification of model polystyrene, (PS), and poly(lactide-co-glycolide),(PLGA), nanospheres by poly(lactide)-poly(ethylene glycol), (PLA:PEG), copolymers has been assessed by in vitro characterisation and in vivo biodistribution studies following subcutaneous administration of the nanospheres to the rat.
METHODS: Three PLA:PEG copolymers were investigated, with PEG chain lengths of 750, 2000 and 5000 Da. The PLA:PEG copolymers were either coated onto the surface of PS and PLGA nanospheres or used as a co-precipitate in the formation of PLGA-PLA:PEG nanospheres. Coating of the nanospheres was confirmed by an increase in their particle size and a corresponding decrease in the surface potential. The kinetics of injection site drainage and lymph node retention was determined over a 24 hour time course for naked, coated and co-precipitated nanosphere systems.
RESULTS: Dependent on the surface characteristics, the distribution of the nanospheres can be significantly modified and the lymph node localisation dramatically enhanced by coating their surfaces with PLA:PEG copolymers or by producing co-precipitate nanospheres of PLGA and PLA:PEG.
CONCLUSIONS: A fully biodegradable nanosphere system has been developed with excellent lymph node targeting characteristics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165539     DOI: 10.1023/a:1012117531448

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Mechanism of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography.

Authors:  F Ikomi; G K Hanna; G W Schmid-Schönbein
Journal:  Radiology       Date:  1995-07       Impact factor: 11.105

2.  Fate of cholesterol-rich liposomes after subcutaneous injection into rats.

Authors:  A Tümer; C Kirby; J Senior; G Gregoriadis
Journal:  Biochim Biophys Acta       Date:  1983-10-04

3.  Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen.

Authors:  H M Patel; N S Tuzel; B E Ryman
Journal:  Biochim Biophys Acta       Date:  1983-12-13

4.  Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers.

Authors:  A E Hawley; L Illum; S S Davis
Journal:  FEBS Lett       Date:  1997-01-06       Impact factor: 4.124

5.  Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes.

Authors:  S M Moghimi; A E Hawley; N M Christy; T Gray; L Illum; S S Davis
Journal:  FEBS Lett       Date:  1994-05-09       Impact factor: 4.124

6.  Assessment of the potential uses of liposomes for lymphoscintigraphy and lymphatic drug delivery. Failure of 99m-technetium marker to represent intact liposomes in lymph nodes.

Authors:  H M Patel; K M Boodle; R Vaughan-Jones
Journal:  Biochim Biophys Acta       Date:  1984-09-07

7.  Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.

Authors:  T M Allen; C B Hansen; L S Guo
Journal:  Biochim Biophys Acta       Date:  1993-07-25

8.  Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.

Authors:  S Stolnik; S E Dunn; M C Garnett; M C Davies; A G Coombes; D C Taylor; M P Irving; S C Purkiss; T F Tadros; S S Davis
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

9.  Carrier activity of sonicated small liposomes containing melphalan to regional lymph nodes of rats.

Authors:  J Khato; A A del Campo; S M Sieber
Journal:  Pharmacology       Date:  1983       Impact factor: 2.547

10.  Lymph node localization of non-specific antibody-coated liposomes.

Authors:  S Mangat; H M Patel
Journal:  Life Sci       Date:  1985-05-20       Impact factor: 5.037

View more
  22 in total

Review 1.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

Review 2.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

Review 3.  Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

Authors:  Yumei Xie; Taryn R Bagby; M S Cohen; M Laird Forrest
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

Review 4.  Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy.

Authors:  Jardin Leleux; Alexandra Atalis; Krishnendu Roy
Journal:  J Control Release       Date:  2015-10-20       Impact factor: 9.776

5.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939

6.  Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability.

Authors:  Claudia Giannavola; Claudio Bucolo; Adriana Maltese; Donatella Paolino; Maria Angela Vandelli; Giovanni Puglisi; Vinecent H L Lee; Massimo Fresta
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

7.  Formation of stable nanocarriers by in situ ion pairing during block-copolymer-directed rapid precipitation.

Authors:  Nathalie M Pinkerton; Arnaud Grandeury; Andreas Fisch; Jörg Brozio; Bernd U Riebesehl; Robert K Prud'homme
Journal:  Mol Pharm       Date:  2012-12-24       Impact factor: 4.939

8.  Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

Authors:  Deepa A Rao; M Laird Forrest; Adam W G Alani; Glen S Kwon; Joseph R Robinson
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

9.  PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.

Authors:  Lisa M Kaminskas; David B Ascher; Victoria M McLeod; Marco J Herold; Caroline P Le; Erica K Sloan; Christopher J H Porter
Journal:  J Control Release       Date:  2013-03-15       Impact factor: 9.776

10.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.